129 related articles for article (PubMed ID: 38394745)
21. Function-Wise Dual-Omics analysis for radiation pneumonitis prediction in lung cancer patients.
Li B; Ren G; Guo W; Zhang J; Lam SK; Zheng X; Teng X; Wang Y; Yang Y; Dan Q; Meng L; Ma Z; Cheng C; Tao H; Lei H; Cai J; Ge H
Front Pharmacol; 2022; 13():971849. PubMed ID: 36199694
[No Abstract] [Full Text] [Related]
22. A nomogram based on pretreatment radiomics and dosiomics features for predicting overall survival associated with esophageal squamous cell cancer.
Kawahara D; Nishioka R; Murakami Y; Emoto Y; Iwashita K; Sasaki R
Eur J Surg Oncol; 2024 Jun; 50(7):108450. PubMed ID: 38843660
[TBL] [Abstract][Full Text] [Related]
23. Dosiomics: Extracting 3D Spatial Features From Dose Distribution to Predict Incidence of Radiation Pneumonitis.
Liang B; Yan H; Tian Y; Chen X; Yan L; Zhang T; Zhou Z; Wang L; Dai J
Front Oncol; 2019; 9():269. PubMed ID: 31032229
[TBL] [Abstract][Full Text] [Related]
24. CT-based dosiomics and radiomics model predicts radiation-induced lymphopenia in nasopharyngeal carcinoma patients.
Huang Q; Yang C; Pang J; Zeng B; Yang P; Zhou R; Wu H; Shen L; Zhang R; Lou F; Jin Y; Abdilim A; Jin H; Zhang Z; Xie X
Front Oncol; 2023; 13():1168995. PubMed ID: 37954080
[TBL] [Abstract][Full Text] [Related]
25. Biological dosiomic features for the prediction of radiation pneumonitis in esophageal cancer patients.
Puttanawarut C; Sirirutbunkajorn N; Khachonkham S; Pattaranutaporn P; Wongsawat Y
Radiat Oncol; 2021 Nov; 16(1):220. PubMed ID: 34775975
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive Pneumonitis Profile of Thoracic Radiotherapy Followed by Immune Checkpoint Inhibitor and Risk Factors for Radiation Recall Pneumonitis in Lung Cancer.
Lu X; Wang J; Zhang T; Zhou Z; Deng L; Wang X; Wang W; Liu W; Tang W; Wang Z; Wang J; Jiang W; Bi N; Wang L
Front Immunol; 2022; 13():918787. PubMed ID: 35795657
[TBL] [Abstract][Full Text] [Related]
27. Development and Validation of a Radiomics Nomogram Using Computed Tomography for Differentiating Immune Checkpoint Inhibitor-Related Pneumonitis From Radiation Pneumonitis for Patients With Non-Small Cell Lung Cancer.
Qiu Q; Xing L; Wang Y; Feng A; Wen Q
Front Immunol; 2022; 13():870842. PubMed ID: 35558076
[TBL] [Abstract][Full Text] [Related]
28. Radiation and immune checkpoint inhibitor-mediated pneumonitis risk stratification in patients with locally advanced non-small cell lung cancer: role of functional lung radiomics?
Thomas HMT; Hippe DS; Forouzannezhad P; Sasidharan BK; Kinahan PE; Miyaoka RS; Vesselle HJ; Rengan R; Zeng J; Bowen SR
Discov Oncol; 2022 Sep; 13(1):85. PubMed ID: 36048266
[TBL] [Abstract][Full Text] [Related]
29. Pseudo-siamese network combined with dosimetric and clinical factors, radiomics features, CT images and 3D dose distribution for the prediction of radiation pneumonitis: A feasibility study.
Feng B; Zhou W; Yang X; Luo H; Zhang X; Yang D; Tao D; Wu Y; Jin F
Clin Transl Radiat Oncol; 2023 Jan; 38():188-194. PubMed ID: 36479235
[TBL] [Abstract][Full Text] [Related]
30. Radiomics and dosiomics for predicting complete response to definitive chemoradiotherapy patients with oesophageal squamous cell cancer using the hybrid institution model.
Kawahara D; Murakami Y; Awane S; Emoto Y; Iwashita K; Kubota H; Sasaki R; Nagata Y
Eur Radiol; 2024 Feb; 34(2):1200-1209. PubMed ID: 37589902
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of
Wang B; Liu J; Zhang X; Wang Z; Cao Z; Lu L; Lv W; Wang A; Li S; Wu X; Dong X
EJNMMI Res; 2023 Feb; 13(1):14. PubMed ID: 36779997
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of survival prognostic models for head and neck cancer patients using machine learning and dosiomics and CT radiomics features: a multicentric study.
Mansouri Z; Salimi Y; Amini M; Hajianfar G; Oveisi M; Shiri I; Zaidi H
Radiat Oncol; 2024 Jan; 19(1):12. PubMed ID: 38254203
[TBL] [Abstract][Full Text] [Related]
33. Prediction of radiation-induced acute skin toxicity in breast cancer patients using data encapsulation screening and dose-gradient-based multi-region radiomics technique: A multicenter study.
Feng H; Wang H; Xu L; Ren Y; Ni Q; Yang Z; Ma S; Deng Q; Chen X; Xia B; Kuang Y; Li X
Front Oncol; 2022; 12():1017435. PubMed ID: 36439515
[TBL] [Abstract][Full Text] [Related]
34. Design and Selection of Machine Learning Methods Using Radiomics and Dosiomics for Normal Tissue Complication Probability Modeling of Xerostomia.
Gabryś HS; Buettner F; Sterzing F; Hauswald H; Bangert M
Front Oncol; 2018; 8():35. PubMed ID: 29556480
[TBL] [Abstract][Full Text] [Related]
35. Lung Inflammation Predictors in Combined Immune Checkpoint-Inhibitor and Radiation Therapy-Proof-of-Concept Animal Study.
Spieler B; Giret TM; Welford S; Totiger TM; Mihaylov IB
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625911
[TBL] [Abstract][Full Text] [Related]
36. Dosimetric Factors and Radiomics Features Within Different Regions of Interest in Planning CT Images for Improving the Prediction of Radiation Pneumonitis.
Jiang W; Song Y; Sun Z; Qiu J; Shi L
Int J Radiat Oncol Biol Phys; 2021 Jul; 110(4):1161-1170. PubMed ID: 33548340
[TBL] [Abstract][Full Text] [Related]
37. Interpretable machine learning for predicting pathologic complete response in patients treated with chemoradiation therapy for rectal adenocarcinoma.
Wang D; Lee SH; Geng H; Zhong H; Plastaras J; Wojcieszynski A; Caruana R; Xiao Y
Front Artif Intell; 2022; 5():1059033. PubMed ID: 36568580
[TBL] [Abstract][Full Text] [Related]
38. Predicting acute radiation induced xerostomia in head and neck Cancer using MR and CT Radiomics of parotid and submandibular glands.
Sheikh K; Lee SH; Cheng Z; Lakshminarayanan P; Peng L; Han P; McNutt TR; Quon H; Lee J
Radiat Oncol; 2019 Jul; 14(1):131. PubMed ID: 31358029
[TBL] [Abstract][Full Text] [Related]
39. Synergizing the interaction of single nucleotide polymorphisms with dosiomics features to build a dual-omics model for the prediction of radiation pneumonitis.
Liang B; Lu X; Liu L; Dai J; Wang L; Bi N
Radiother Oncol; 2024 Jul; 196():110261. PubMed ID: 38548115
[TBL] [Abstract][Full Text] [Related]
40. Incidence and risk factors for pneumonitis among patients with lung cancer who received immune checkpoint inhibitors after palliative thoracic radiotherapy.
Saito S; Abe T; Iino M; Aoshika T; Ryuno Y; Ohta T; Igari M; Hirai R; Kumazaki Y; Yamaguchi O; Kaira K; Kagamu H; Noda SE; Kato S
J Radiat Res; 2021 Jul; 62(4):669-675. PubMed ID: 34121123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
